Mufin Green Finance posted a 345.6% jump in Q1 FY27 net profit to ₹14.01 crore, driving its stock to a new 52-week high of ₹143.90. The growth was led by a strong expansion in Assets Under Management (AUM) and higher disbursements in its mediclaim financing and payroll lending segments.
Mufin Green Finance shares reached a 52-week high of ₹143.90 on the National Stock Exchange on August 12, 2026, following the release of strong first-quarter financial results for fiscal year 2027. The company, which operates as a non-banking financial company (NBFC), reported a profit after tax of ₹14.01 crore, a significant increase of 345.6% compared to the same period last year.
Revenue from operations also saw a sharp rise, growing by 60.06% to ₹76.86 crore. This performance was supported by a 69.4% year-on-year expansion in the company's Assets Under Management (AUM), which stood at ₹1,599.23 crore as of June 30, 2026.
Growth Drivers in Specialized Lending
The company's growth was primarily fueled by two key areas: mediclaim financing and payroll-linked lending, known as 'Salary Saathi.' The mediclaim financing vertical, which accounts for 42% of total AUM, disbursed ₹247.08 crore during the quarter across more than 48,000 loans. Meanwhile, the Salary Saathi segment saw increased activity, particularly after the company expanded its presence into Assam in March 2026.
To support this growth, Mufin Green Finance has focused on managing its funding costs. The company successfully reduced its borrowing cost to 11.17% in the first quarter, aided by new partnerships with lenders such as Union Bank of India and Wint Wealth. As of June 2026, the company maintained a healthy Capital to Risk Assets Ratio of 30.55%, providing a cushion for future lending operations.
Financial Health and Investor Monitorables
While the company has shown strong growth, investors often track the quality of the loan book as an NBFC scales. For the quarter ending June 2026, the company reported a Gross NPA (Non-Performing Asset) ratio of 1.91% and a Net NPA ratio of 1.63%. Maintaining or improving these asset quality metrics will be important as the portfolio grows.
Another point for shareholders to monitor is the stock's valuation, as it currently trades at a multiple of approximately 4.7 times its book value. Additionally, the company faces risks common to the sector, including potential funding cost volatility if interest rates change and competitive pressure from other lenders entering the specialized premium financing space. Future updates regarding the company’s ability to sustain its margins, manage credit costs, and continue its expansion into new geographies will be key areas for investors to follow.